Related Experiment Video

Updated: Aug 13, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

19.1K

Engineering next-generation therapeutics with antibody-mimetic 'plug & play' molecular assembly technology

Yujie Sheng1, Kourosh H Ebrahimi1

  • 1Institute of Pharmaceutical Science, King's College London, London, UK.

Nanomedicine (London, England)
|December 17, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Protein nanocagesantibody-mimeticdrug deliveryferritinnanomedicinepersonalized medicine‘plug & play’

More Related Videos

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.2K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

8.2K

Related Experiment Videos

Last Updated: Aug 13, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

19.1K
Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.2K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

8.2K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Articles linked to this work by shared authors, journal, and citation graph.

Discovery of an Antiviral Electron Transfer Process to Create Catalytically Self-Sufficient Viral Restriction Factors.

Angewandte Chemie (International ed. in English)·2026

SH3PXD2B is the critical host factor promoting the entry of mycobacteria.

Applied and environmental microbiology·2026

Controlling nanocage assembly, towards developing a one-health "plug & play" platform for targeted therapy.

Chemical communications (Cambridge, England)·2025

The [2Fe-2S] cluster of mitochondrial outer membrane protein mitoNEET has an O2-regulated nitric oxide access tunnel.

FEBS letters·2025

A Versatile Virus-Mimetic Engineering Approach for Concurrent Protein Nanocage Surface-Functionalization and Cargo Encapsulation.

Small (Weinheim an der Bergstrasse, Germany)·2024

Multi-structural molecular docking (MOD) combined with molecular dynamics reveal the structural requirements of designing broad-spectrum inhibitors of SARS-CoV-2 entry to host cells.

Scientific reports·2023

Cationic lipid-based targeted nanocarriers for respiratory diseases in children: prospects and challenges.

Nanomedicine (London, England)·2026

LPR-1-Mediated targeted intranasal delivery of lentinan-loaded polymeric nanocarriers for GBM therapy via modulation of apoptotic signalling.

Nanomedicine (London, England)·2026

Intradermal immunoengineering with mRNA.

Nanomedicine (London, England)·2026

Considerations for nanoscale drug-delivery systems for the cornea.

Nanomedicine (London, England)·2026

Advances in the development and application of nanofibrous systems for intranasal drug delivery.

Nanomedicine (London, England)·2026

Bacterial extracellular vesicles: mechanisms, engineering strategies, and therapeutic potential for inflammatory bowel disease.

Nanomedicine (London, England)·2026

Preparation of Oxide Nanofibers for Analysis by Transmission Electron Microscopy.

Microscopy research and technique·2026

Hierarchical drug-releasing nanocomposite hydrogel for postoperative synergistic chemo-photothermal therapy of uveal melanoma.

Materials today. Bio·2026

Nanoarchitectonics Approach for Hydrogel Surface Functionalization via Self-Assembly of Terminally Modified Cello-oligosaccharides.

ACS polymers Au·2026

Enhanced antibiofilm and antifungal activities of a hexanophenone nanoformulation against Candida albicans: a nanotechnology-driven approach.

Journal of materials chemistry. B·2026

Oxidation-Induced Anisotropic Subsurface Segregation in SnTe Nanowires.

Chemistry of materials : a publication of the American Chemical Society·2026

Ultra-low-temperature a-Si:H sputtering for high-quality photonic integration.

Optics express·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us